PI Publications
- 2025Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer. Redox Biology.79:103458.
Jog E, Jainarayanan AK, Ferlita A, Chakraborty A, Dalwai A, Yahya S, Shivashankar A, Choudhary B, Chandramouli A, Kazi M, Jain D, Khapre N, Akshaya B, Khan B, Gera P, Patil P, Thorat R, Verma N, Sehgal L, Saklani A, Kamat S, Dalal SN, Choudhary N (2025).
Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research.Chaudhary N, La Ferlita A, Choudhary BS, Jog E, Kazi M, Yahya S, Dalwai A, Ostwal V, Kumar S, Redkar S, Khapare N, Kailaje V, B A, Gera P, Bal M, Verma N, Thorat R, Saklani A, Sehgal L, Dalal SN (2025)
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1):55. PMID: 39972345.Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N
Development and characterization of pegylated Fe3O4-CAPE magnetic nanoparticles for targeted therapy and hyperthermia treatment of colorectal cancer. Scientific Reports 215(1):26008.Yahya S, Pushpanathan S, Jan S, Chaudhary N, Parray R, Gandhi KA, Thangavel K, Krishnan K, Sudhandiran G (2025).
- 2024LCN2 promotes focal adhesion formation and invasion by stimulating Src activation. bioRxiv.
Choudhary BS, Chaudhary N, Vijan A, Mandal D, Pilankar L, Gawand S, Khan B, Shivashankar A, Doloi R, Joshi N, Das M, Dalal SN (2024)
Spatial Epidemiology of Signet-ring Cell Colorectal Cancer in India. Saudi Journal of Medicine and Medical Sciences. 12(1): 71-75Kazi M, Patel H, Choudhary N, Jain A, Dudhat S, Naik S, Desouza A, Saklani A (2024)
- 2023GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition. Preprint.
Chaudhary N, Choudhary B. S., Patra S, Malvankar S, Shivashankar A, Jog E, V. V Kailje, Khanna S, Manna S, Sahoo S, Soundharya R, Jolly M.R., Dalal S.N. and Verma N
Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration. FEBS letters.Choudhary, B. S., Chaudhary, N., Shah, M., Dwivedi, N., PK, S., Das, M., & Dalal, S. N.
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. bioRxivChaudhari N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Barr J, Dani J, Verma N (2024)
- 2022Plakophilin3 loss leads to an increase in autophagy and radio-resistance. Biochemical and Biophysical Research Communications, 620, 1-7.
Chaudhary, N., Joshi, N., Doloi, R., Shivashankar, A., Thorat, R., & Dalal, S. N.
- 2021Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. International Journal of Cancer, 149(7), 1495-1511.
Chaudhary, N., Choudhary, B. S., Shah, S. G., Khapare, N., Dwivedi, N., Gaikwad, A., ... & Dalal, S. N.
Tumor-specific overexpression of histone gene, H3C14 in gastric cancer is mediated through EGFR-FOXC1 axis. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 1864(4-5), 194703.Rashid, M., Shah, S. G., Verma, T., Chaudhary, N., Rauniyar, S., Patel, V. B., ... & Gupta, S.
“Antibodies against Lipocalin-2 and use thereof”Sorab. N. Dalal, Manjula Das, Sujan K Dhar, Smitha P K, Nazia Chaudhary, et al. Publication no. W0/2021/137254. 08 July S202. PCT application no. PCT/IN2020/051068.
- 2018Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation. Experimental Cell Research, 369(2), 251-265.
Basu, S., Chaudhary, N., Shah, S., Braggs, C., Sawant, A., Vaz, S., ... & Dalal, S. N.
- 2016